Effect of glycopyrrolate on the postoperative urine output of patients following kidney transplantation: a retrospective observational study

Bon Sung Koo,Sun Young Park,Youn Sil Jang,Young Hoon Woo,Sanghoon Song,Jae Hwa Yoo,Mun Gyu Kim,Ji Won Chung,Sang Ho Kim,Ho Bum Cho
DOI: https://doi.org/10.1177/03000605231202144
2023-10-07
Journal of International Medical Research
Abstract:Journal of International Medical Research, Volume 51, Issue 10, October 2023. ObjectivesTo compare the urine output and estimated glomerular filtration rate (eGFR) of patients postoperatively administered sugammadex or glycopyrrolate 7 days following kidney transplantation (KT).MethodsWe retrospectively enrolled 134 consecutive patients who underwent KT under general anesthesia. Their urine output and eGFR were recorded every 24 hours between postoperative day (POD) 1 and 7. We used regression analysis to evaluate the relationship between the reversal agent administered and the outcomes of the participants.ResultsThe urine output and eGFR of the participants did not differ between the two groups. Multivariate analysis showed that body mass index (BMI) (odds ratio (OR) 1.21; 95% confidence interval (CI) 1.05–1.40), diabetes mellitus (OR 3.14; 95% CI 1.07–9.16), neurovascular disease (OR 7.00; 95% CI 1.61–30.42), and the duration of surgery (OR 1.01; 95% CI 1.00–1.01) were associated with lower urine output on POD 7. In addition, only BMI (OR 1.25; 95% CI 1.09–1.42) was associated with low eGFR on POD 7.ConclusionsThe urine output and eGFR of patients administered sugammadex or glycopyrrolate following KT did not differ 7 days later. Moreover, glycopyrrolate does not affect urine output or eGFR on POD 7, according to multivariate regression analysis.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?